Clinical Trial Update: A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of avelumab in penile cancer patients unfit for or progressed after platinum-based chemotherapy is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Penile Cancer, Advanced Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING